-
Non-canonical Amino Acids for in vitro Display Systems
AstraZeneca aims to build a world-class peptide discovery platform combining phage and mRNA display technologies with incorporation of non-canonical amino acids (ncAAs). -
ASO and siRNA Therapeutics for CNS and Liver Disorders
Nissan Chemical Corporation, a forerunner in chemical innovations, is seeking novel ASO and siRNA therapeutics for CNS and liver diseases. -
Seeking Novel Disease Models of Macular Degeneration
Daiichi Sankyo is seeking disease models of macular degeneration—specifically atrophic age-related macular degeneration (AMD) and Stargardt disease—that have high translational potential for clinical use. -
Cell-free Synthesis of Transfection-grade Plasmid DNA for Automated Processing
Daiichi Sankyo, a global pharmaceutical company focused on creating innovative pharmaceuticals, is seeking a fully cell-free, in vitro technology capable of synthesizing and amplifying plasmid DNA without relying on E. coli. -
Reducing Organic Impurities in Phosphoric Acid Production
ICL Group, a leading global specialty minerals company and producer of phosphoric acid for chemical manufacturing, is seeking novel and mature solutions to remove or treat organic impurities from the phosphoric acid production process -
Seeking Novel Therapeutic Approaches in Oncology
BSM Biotech Holding seeks innovative discovery research projects in oncology to identify novel therapeutic approaches for further development -
Healthcare Improvement (HCI) Initiative - Alzheimer's Disease Care
Lilly seeks proposals for healthcare improvement projects that reduce the time from biomarker-confirmed diagnosis of early Alzheimer's disease. -
NVIDIA Academic Grant Program
NVIDIA's Academic Grant Program provides computational resources and support to full-time faculty members at accredited academic institutions who are advancing research using NVIDIA technology across three strategic areas: Simulation and Modeling, Data Science, and Robotics and Edge AI. -
NIDA’s 2025 “$100,000 Start an SUD Startup” Challenge
The National Institute on Drug Abuse (NIDA), one of the components of the National Institutes of Health (NIH), has released its annual “$100,000 Start an SUD Startup” Challenge for 2025. -
Novel Approaches Mimicking the Sensory Attributes of Alcohol
Private company seeks innovative compounds and approaches to replicate alcohol's multisensory impact in non-alcoholic beverages.